ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at Upcoming Investor Conference
5/3/2013 7:50:23 AM
More...
|
ImmunoGen, Inc. (IMGN) Reports Third Quarter Fiscal Year 2013 Financial Results and Provides Quarterly Update
4/26/2013 6:29:00 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Third Quarter Fiscal Year 2013 Financial Results
4/18/2013 7:16:13 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Preclinical Findings With Its IMGN289 Product Candidate for the Treatment of EGFR-Overexpressing Cancers
4/10/2013 11:17:01 AM
More...
|
ImmunoGen, Inc. (IMGN) to Ring the NASDAQ Stock Market Closing Bell
4/1/2013 10:27:29 AM
More...
|
ImmunoGen, Inc. (IMGN) Attains Patient Enrollment Milestone in IMGN901 NORTH Trial
2/12/2013 9:55:47 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences
2/6/2013 6:09:23 AM
More...
|
ImmunoGen, Inc. (IMGN) Reports Second Quarter Fiscal Year 2013 Financial Results and Provides Quarterly Update
1/25/2013 6:22:25 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Second Quarter Fiscal Year 2013 Financial Results
1/18/2013 6:23:05 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at the 31st Annual J.P. Morgan Healthcare Conference
1/2/2013 6:19:16 AM
More...
|
|